Search results for "chronic"

showing 10 items of 3309 documents

Effects and underlying mechanisms of unstable shoes on chronic low back pain : a randomized controlled trial

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://journals.sagepub.com/doi/abs/10.1177/0269215517753972?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=crea Este es el postprint del siguiente artículo: Lisón, JF., Ortega-Santana, B., Antón-Nogués, Á., González-Requena, P., Vera-Hervás, C., Doménech-Fernández, J. et al. (2018). Effects and underlying mechanisms of unstable shoes on chronic low back pain : a randomized controlled trial. Clinical Rehabilitationol. 32, n. 5 (may), pp. 654-662, que se ha publicado de forma definitiva en https://doi.org/10.1177/0269215517753972 This is the pre-peer reviewed ve…

Malemusculoskeletal diseasesmedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationElectromyographylaw.invention03 medical and health sciencesDisability Evaluation0302 clinical medicineRandomized controlled triallawmedicineHumansIn patientRange of Motion ArticularBackache - Treatment.Spine - Electromyography.Abdominal MusclesChronic pain - Treatment.Lumbar Vertebraemedicine.diagnostic_testbusiness.industryElectromyographyBack MusclesRehabilitation030229 sport sciencesMiddle AgedGaitChronic low back painShoesDolor crónico - Tratamiento.Lumbago - Tratamiento.Orthopedic surgeryPhysical therapyColumna vertebral - Electromiografía.Lumbar spineFemaleChronic PainRange of motionbusinessLow Back Pain030217 neurology & neurosurgery
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gießen, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting β2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

2019

Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with chronic upper airways disease. The 1,817 (958 males, mean age 49 years) patients were evaluated at baseline (T0) and after one (T1) and two (T2) …

Maleupper airwaysPlant Extractsgrapefruit seed extractthermal waterWaterMiddle AgedNOOtolaryngologyOtorhinolaryngologic DiseasesTreatment OutcomeEquipment and SuppliesHealth Care SurveysSeedshyaluronic acidupper airways chronic disease thermal water hyaluronic acid grapefruit seed extractHumansOriginal ArticleFemalechronic diseaseCitrus paradisi
researchProduct

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice.

2019

Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with chronic upper airways disease. The 1,817 (958 males, mean age 49 years) patients were evaluated at baseline (T0) and after one (T1) and two (T2) …

Maleupper airwaysupper airways exacerbated chronic disease thermal water hyaluronic acid grapefruit seed extractPlant Extractsexacerbated chronic diseasegrapefruit seed extractExacerbated chronic disease; Grapefruit seed extract; Hyaluronic acid; Thermal water; Upper airwaysthermal waterWaterMiddle AgedNOOtolaryngologyOtorhinolaryngologic DiseasesTreatment OutcomeEquipment and SuppliesRecurrenceHealth Care SurveysChronic DiseaseSeedshyaluronic acidHumansFemaleOriginal ArticleCitrus paradisiActa bio-medica : Atenei Parmensis
researchProduct

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A…

2013

International audience; Background & AimsTreatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemia, which has been managed by reducing ribavirin dose and/or erythropoietin therapy. We assessed the effects of these anemia management strategies on rates of sustained virologic response (SVR) and safety.MethodsPatients (n = 687) received 4 weeks of peginterferon and ribavirin followed by 24 or 44 weeks of boceprevir (800 mg, 3 times each day) plus peginterferon and ribavirin. Patients who became anemic (levels of hemoglobin approximately ≤10 g/dL) during the study treatment period (n = 500) were assigned to groups that were managed by ribavi…

Maleviruses[SDV]Life Sciences [q-bio]Hepacivirusmedicine.disease_causeGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawErythropoiesisIncidenceGastroenterologyDisease Managementvirus diseasesAnemiaMiddle AgedRecombinant Proteins3. Good healthTreatment Outcome030220 oncology & carcinogenesisDrug Therapy CombinationFemale030211 gastroenterology & hepatologyAlgorithmsmedicine.drugmedicine.medical_specialtyGenotypeProlineSide effectAnemiaHepatitis C virusInterferon alpha-2Antiviral Agents03 medical and health sciencesInternal medicineBoceprevirRibavirinmedicineHumansErythropoietinDAADose-Response Relationship DrugHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C Chronicbiochemical phenomena metabolism and nutritionmedicine.diseasedigestive system diseasesSide EffectLogistic ModelschemistryErythropoietinImmunologyHemoglobinbusinessEPO
researchProduct

“Khubz as iqṭā' in four authors from the Ayyubid and early Mamluk period”

2012

Khubz as Iqta

Mamluks iqṭā' Syria mamluk Chronicles
researchProduct

COMPARING THE MARSHALL PLAN AND THE EUROPEAN NEXT GENERATION UE. Models and Legal Tools of International and Supernational Cooperation to Promote Eco…

2022

The article analyzes and compares the European Recovery Plan of 1948, commonly known as the Marshall Plan, for the reconstruction of Europe after the Second World War (paragraphs 2, 2.1, 2.2), and the Next Generation EU (paragraphs 3, 3.1) through the lens and methods of legal comparison and historical analysis. As the description of the law cannot ignore the historicization of the object of study, such comparison is carried out inductively, through the analysis of the legal mechanisms in their concrete attitudes and the construction of descriptive schemes of facts, having regard to the legal discipline, but also to the functional profiles and the context in which the rules are conceived. T…

Marshall Plan Next Generation EU compliance strategies conditionalities economic development comparative method diachronic comparison.Settore IUS/02 - Diritto Privato ComparatoSettore IUS/21 - Diritto Pubblico Comparato
researchProduct

Maternal coping strategies in response to a child's chronic and oncological disease: a cross-cultural study in Italy and Portugal

2013

A child's oncological or chronic disease is a stressful situation for parents. This stress may make it difficult for appropriate management strategies aimed at promoting the child's wellbeing and helping him or her cope with a disease to be adopted. In particular, this study focuses on the possible connections between the variable national cultural influences and the parental strategies used to cope with a child's severe disease by comparing the experiences of Italian and Portuguese mothers. The study investigates differences and cross-cultural elements among the coping strategies used by Italian and Portuguese mothers of children with oncological or chronic disease. Two groups of mothers t…

Maternal copingmedicine.medical_specialtyPediatricsAlternative medicinelcsh:MedicineSevere diseaseoncological diseaseDiseasePediatricsChronic diseaseArticleemotional distressmaternal coping; chronic disease; oncological disease; emotional distressEmotional distressmedicineCross-culturalmaternal copingCultural influencematernal coping chronic disease oncological disease emotional distressbusiness.industrylcsh:Rlcsh:RJ1-570lcsh:Pediatricslanguage.human_languageChronic diseaselanguagePortuguesebusinesschronic diseaseClinical psychology
researchProduct

How and for whom does a positive affect intervention work in fibromyalgia: An analysis of mediators and moderators.

2019

Objectives: Psychological interventions designed to enhance positive affect are promising ways to promote adaptive functioning in people with chronic pain. However, few studies have addressed the efficacy of positive affect interventions in chronic pain populations and examined which patients can benefit more from them. The aim of the present study was to identify mediators and moderators of the best possible self intervention (BPS) in fibromyalgia patients.Methods: We used data from a previous randomized controlled trial that examined changes in pain interference, depression, self‐efficacy and quality of life after the BPS intervention.Results: Mediation analyses showed that depression med…

Mediation (statistics)FibromyalgiaPsychological interventionsPsychological interventionChronic painAffect (psychology)Best Possible Self Intervention (BPS)law.invention03 medical and health sciencesDepressive symptomatology0302 clinical medicineRandomized controlled triallawIntervention (counseling)FibromyalgiaMedicineHumansPain Management030212 general & internal medicinebusiness.industryChronic painMediationPositive affect interventionsmedicine.diseaseFacial ExpressionAnesthesiology and Pain MedicineRuminationQuality of Lifesense organsmedicine.symptomChronic PainbusinessFibromyalgia patients030217 neurology & neurosurgeryClinical psychology
researchProduct

Executive summary of EPOS 2020 including integrated care pathways.

2020

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012 (1-3). The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become…

Medical educationExecutive summaryEvidence-based practicebusiness.industryOutcome measurementsDelivery of Health Care IntegratedMEDLINEGeneral MedicineGuidelineSinus surgery3. Good healthIntegrated care03 medical and health sciences0302 clinical medicineNasal PolypsOtorhinolaryngologyChronic DiseaseMedicinePosition paperHumansSinusitis030223 otorhinolaryngologybusinessRhinitisRhinology
researchProduct